Categories: News

Connected Care’s Golden State Medicare Health Plan Taps AdhereHealth’s Technology to Help Improve Member Medication Adherence

NEWPORT BEACH, Calif., May 1, 2019 /PRNewswire/ — Golden State Medicare Health Plan, an HMO that specializes in the care of seniors, is deploying technology that uses advanced analytics to resolve medication adherence issues that affect patient outcomes and Medicare Advantage Star Ratings. The technology is provided by AdhereHealth™, a healthcare technology solutions leader that focuses on medication adherence and currently supports nearly 10 million consumers across the nation.

“We take a physician-led and member-centric approach – using innovative technologies is central to this mission,” said Dr. Sanjay Patil, CEO of Golden State Medicare Health Plan. “AdhereHealth’s technology helps us directly engage with our members to ensure medication adherence and improved health, an effort we can measure through higher Star Ratings.”

AdhereHealth’s technology platform, Adhere™, uses advanced analytics to identify members who need support in their medication adherence. Members experiencing medication adherence issues often are challenged by social determinants, such as poor health literacy and access to care. AdhereHealth’s nation-wide network of licensed clinicians use available health plan data and clinical workflow tools to engage directly with the consumer and their doctors to improve adherence.

“Our data-driven approach creates a positive experience for the consumer and promotes medication adherence that meaningfully improves healthcare outcomes,” said Jason Z. Rose, AdhereHealth CEO. “This also aligns perfectly with Golden State’s goal to use advanced technology to build a foundation for driving future growth and innovation across California.”

About AdhereHealth™
AdhereHealth™ is a healthcare technology solutions leader supporting health plans, self-insured employers and other risk-bearing entities for medication adherence insights and improved healthcare outcomes. The company’s Adhere™ platform touches nearly 10 million consumers through advanced technologies, at-risk engagement services and home-delivered pharmacy. The integrated set of solutions address an estimated $300 billion of unnecessary annual medical costs attributed to medication adherence issues. The company is headquartered in the Nashville suburb of Brentwood, Tennessee. For more information, please visit www.adherehealth.com.

About Golden State Medicare Health Plan
Golden State Medicare Health Plan (HMO) is a physician-led, technology-enabled Medicare Advantage Prescription Drug (MAPD) plan in California that serves its members with C.A.R.E. – compassion, accountability, respect and excellence. The plan, recently acquired by Connected Care Health Services, Inc., focuses on providing members a frictionless healthcare experience, removing barriers to health, and prioritizing access to high-cost, life-saving, life-sustaining medications that can transform health outcomes. Learn more at www.gsmhp.com.  

Contact:
Media@cchealth.com  

 

View original content:http://www.prnewswire.com/news-releases/connected-cares-golden-state-medicare-health-plan-taps-adherehealths-technology-to-help-improve-member-medication-adherence-300841875.html

SOURCE Connected Care Health Services, Inc.

Staff

Recent Posts

MEDITECH Announces the Passing of Founder and Chairman A. Neil Pappalardo

Reflections on his 56-year legacy as a tech pioneer and founder of the EHR industryCANTON,…

1 hour ago

eClinicalWorks and Sunoh.ai Assist Healthy Horizons Clinic Save Over Two Hours Daily on Clinical Documentation

Multispecialty practice transforms patient care, improves operational efficiency, and increases patient engagement with AI medical…

1 hour ago

TRNR Publishes Comprehensive Sportstech Documentation for Shareholders

Timeline and Source Materials Now Available at interactivestrength.com/sportstech AUSTIN, TEXAS / ACCESS Newswire / January…

1 hour ago

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

4 hours ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…

4 hours ago

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…

4 hours ago